Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2005-05-10
2005-05-10
Low, Christopher S. F. (Department: 1653)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C435S007100, C435S069600, C435S325000, C514S002600, C514S012200, C530S350000
Reexamination Certificate
active
06890514
ABSTRACT:
The present invention relates generally to a method of identifying a subject having an increased risk of developing cervical cancer based on levels of IGF-II in serum and levels of EGF-R and HPV-E6/E7 in cervical epithelial cells and in serum.
REFERENCES:
patent: 5591595 (1997-01-01), Van Aken et al.
patent: 5679509 (1997-10-01), Wheeler et al.
patent: 0 531080 (1992-01-01), None
patent: WO 9855872 (1998-12-01), None
Blomfield et al., “Can women at risk of cervical abnormality be identified?”Brit J. of Obstet. Gyn. 105:486-492 (1998).
Cheng et al., “Translocation of the B Cell Antigen Receptor into Lipid Rafts Reveals a Novel Step in Signaling,”J. Immunol. 166:3693-3701 (2001).
Choo et al., “Differentiation-independant constitutive expression of the human papillomavirus type 16 E6 and E7 oncogenes in the CaSki cervical tumour cell line,”J. Gen. Virol. 75:1139-1147 (1994).
Genest et al., “Qualifying the Cytologic Diagnosis of Atypical Squamous Cells of Undetermined Signiflcance Affects the Predictive Value of a Squamous Intraepithellal Lesion on Subsequent Biopsy,”Arch. Pathol. Lab Med. 122:338-341 (Apr. 1998).
Kihlberg et al., “Characterization of the binding properties of protein LG, an Immunoglobulin-binding hybrid protein,”Eur. J. Biochem 240(3):556-563 (1996).
Kim et al., “Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells,”Int. J Gynecol Cancer 10:157-164 (2000).
Kim et al., “Cervical Cancer with Paraaortic Metastases: Signiflcance of Residual Paraaortic Disease after Surgical Staging,”Gyn. Onc. 69:243-247 Article No. GO985012 (1998).
Kwack et al., “Functional consequences of the interaction between T-cell antigen receptors and Fc γRs on T cells,”Immunol. Lett. 44(2-3):139-143 (1995).
Mathur et al., “Target Antigen(s) in Endometrial Autoimmunity Of Endometriosis,”Autoimmunity 20:211-222 (1995).
Mathur et al., “Cervical Epidetmal Growth Factor-Receptor (EGF-R) and Serum Insulin-Like Growth Factor II (IGF-II) Levels are Potential Markers for Cervical Cancer,”Am. J. Reproduct. Immunol. 44:222-230 (2000).
Parker et al., “Cancer Statistics, 1997. ”CA Cancer J. Clin 47:1-27 (1997).
Steller et al., “Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells,”Proc. Natl. Acad. Sci. 92:11970-11974 (1995).
Van Dessell et al., “Serum and Follicular Fluid Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, and IGF-Binding Protein-1 and -3 During the Normal Menstrual Cycle,”J. Clin. End. Metab. 81(3):1224-1231 (1996).
Sun et al., “Different HPV16 E6/E7 Oncogne Expression Patterns in Epithelia Reconstructed from HPV16-immortalized Human Endocervical Cells and Genital Keratinocytes”, Oncogene, vol. 15, No. 20, Nov. 1997, pp. 2399-2408.
Park et al., “HPV-16-Related Proteins as the Serologic Markers in Cervical Neoplasia”, Gynecologic Oncology, vol. 69, No. 1, Apr. 1998, pp. 47-55.
Marthur et al., “Human Papilloma Virus (HPV)-E6/E7 and Epidermal Growth Factor Receptor (EGF-R) Protein Levels in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN), American Journal of Reproductive Immunology, Vo. 46, No. 4, Oct. 2001, pp. 280-287.
Mathur Rajesh S.
Mathur Subbi P.
Kam Chih-Min
Low Christopher S. F.
MUSC Foundation for Research Development
Needle & Rosenberg P.C.
LandOfFree
Methods for determining risk of developing cervical cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for determining risk of developing cervical cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for determining risk of developing cervical cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384421